Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter

BACKGROUND: In a recent trial, cyclosporine A (CsA) failed to reduce infarct size in acute stroke patients treated with intravenous thrombolysis. White matter (WM) and gray matter (GM) may have distinct vulnerability to ischemia and response to therapy. Using final infarct size and lesion growth as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Elodie, Mewton, Nathan, Bouvier, Julien, Chauveau, Fabien, Ritzenthaler, Thomas, Mechtouff, Laura, Derex, Laurent, Buisson, Marielle, Berthezène, Yves, Ovize, Michel, Nighoghossian, Norbert, Cho, Tae-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406390/
https://www.ncbi.nlm.nih.gov/pubmed/28496428
http://dx.doi.org/10.3389/fneur.2017.00151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406390/
https://www.ncbi.nlm.nih.gov/pubmed/28496428
http://dx.doi.org/10.3389/fneur.2017.00151

Ejemplares similares